Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 11/20 | 0.65 |
| ▸ | FAAH | O00519 | 6/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | MAPT | P10636 | 2/20 | 0.62 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.62 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.62 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.62 |
| ▸ | TP53 | P04637 | 1/20 | 0.62 |
| ▸ | PKM | P14618 | 1/20 | 0.62 |
| ▸ | HPGD | P15428 | 1/20 | 0.62 |
| ▸ | XBP1 | P17861 | 1/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | HTT | P42858 | 1/20 | 0.62 |
| ▸ | RECQL | P46063 | 1/20 | 0.62 |
| ▸ | RAB9A | P51151 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.62 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.62 |
| ▸ | PTGS1 | P23219 | 7/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19514746 | 0.93 | MGLL (0.70) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL179955 | 0.91 | MGLL (0.71) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL18040141 | 0.91 | MGLL (0.71) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL19514774 | 0.91 | MGLL (0.71) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL34594 | 0.91 | MGLL (0.56) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL797328 | 0.80 | MGLL (0.62) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL155748 | 0.80 | MGLL (1.00) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL331378 | 0.80 | MGLL (0.88) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL258626 | 0.78 | MGLL (1.00) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL5383694 | 0.78 | MGLL (1.00) | MGLLFAAHALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110643032-B | Eight-arm polyethylene glycol, preparation method, functionalized derivative and modified biologically-relevant substance | 厦门赛诺邦格生物科技股份有限公司 | 2022-01-28 | — | — | CN | claimed |
| CN-110643032-A | Eight-arm polyethylene glycol, preparation method, functionalized derivative and modified biologically-relevant substance | 厦门赛诺邦格生物科技股份有限公司 | 2020-01-03 | — | — | CN | claimed |
| CN-115244176-A | Conjugates of guide RNA-CAS protein complexes | 钟明宏 | 2022-10-25 | — | — | CN | disclosed |
| US-11324827-B2 | Multifunctionalized polyethylene glycol derivative and preparation method therefor | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2022-05-10 | — | — | US | disclosed |
| US-20220054619-A1 | LIPOPEPTIDE BUILDING BLOCKS AND SYNTHETIC VIRUS-LIKE PARTICLES | VIROMETIX AG (CH) | 2022-02-24 | — | — | US | disclosed |
| CN-110643032-B | Eight-arm polyethylene glycol, preparation method, functionalized derivative and modified biologically-relevant substance | 厦门赛诺邦格生物科技股份有限公司 | 2022-01-28 | — | — | CN | disclosed |
| EP-3897708-A1 | LIPOPEPTIDE BUILDING BLOCKS AND SYNTHETIC VIRUS-LIKE PARTICLES | Virometix AG (CH) | 2021-10-27 | — | — | EP | disclosed |
| CN-113260377-A | Lipopeptide building blocks and synthetic virus-like particles | 维罗米蒂克斯股份公司 | 2021-08-13 | — | — | CN | disclosed |
| WO-2020127728-A1 | LIPOPEPTIDE BUILDING BLOCKS AND SYNTHETIC VIRUS-LIKE PARTICLES | VIROMETIX AG (CH) | 2020-06-25 | — | — | WO | disclosed |
| US-10660969-B2 | Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2020-05-26 | — | — | US | disclosed |
| CN-110643032-A | Eight-arm polyethylene glycol, preparation method, functionalized derivative and modified biologically-relevant substance | 厦门赛诺邦格生物科技股份有限公司 | 2020-01-03 | — | — | CN | disclosed |
| EP-1603590-A2 | INFLUENZA VIRUS VACCINE | Merck & Co. Inc. (US) | 2005-12-14 | — | — | EP | disclosed |
| WO-2005003775-A2 | GLYCOCONJUGATES AND THEIR USE AS POTENTIAL VACCINES AGAINST INFECTION BY SHIGELLA FLEXNERI | INSTITUT PASTEUR (FR) | 2005-01-13 | — | — | WO | disclosed |
| WO-2004080403-A2 | INFLUENZA VIRUS VACCINE | MERCK & CO. INC. (US) | 2004-09-23 | — | — | WO | disclosed |
| US-20030224992-A1 | Transcription factor modulators and uses thereof | PRAECIS PHARMACEUTICALS INC. | 2003-12-04 | — | — | US | disclosed |
| WO-2003077931-A1 | TRANSCRIPTION FACTOR MODULATORS AND USES THEREOF | PRAECIS PHARMACEUTICALS, INC. (US) | 2003-09-25 | — | — | WO | disclosed |
| EP-0726770-A4 | SULFAMETHOXAZOLE-SPECIFIC IMMUNOSUPPRESSIVE AGENTS | CORTECH INC (US) | 1998-02-04 | — | — | EP | disclosed |
| US-5599912-A | DEXTRAN DERIVATIVES WHICH ALSO CONTAIN SULFAMETHOXAZOLE GROUPS, FOR TREATING UNDESIRED IMMUNE RESPONSES TO DRUGS WHICH ALSO CONTAIN THOSE GROUPS | CORETECH, INC. (US) | 1997-02-04 | — | — | US | disclosed |
| EP-0726770-A1 | SULFAMETHOXAZOLE-SPECIFIC IMMUNOSUPPRESSIVE AGENTS | CORTECH, INC. (US) | 1996-08-21 | — | — | EP | disclosed |
| WO-1995007087-A1 | SULFAMETHOXAZOLE-SPECIFIC IMMUNOSUPPRESSIVE AGENTS | CORTECH, INC. (US) | 1995-03-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10660969-B2 | Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof | MRPL38, ALG8, COG8 | MGLL 539/4885FAAH 2358/4885ALDH1A1 787/4885 |
| US-20220054619-A1 | LIPOPEPTIDE BUILDING BLOCKS AND SYNTHETIC VIRUS-LIKE PARTICLES | VSIR, VIP, LRBA | MGLL 444/4885FAAH 1579/4885ALDH1A1 4864/4885 |
| US-11324827-B2 | Multifunctionalized polyethylene glycol derivative and preparation method therefor | HDGF, F11, F12 | MGLL 1181/4885FAAH 1494/4885ALDH1A1 1582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.